Tanios Bekaii-Saab, MD, FACP, on which patients are most likely to benefit from later-line checkpoint inhibitors for advanced gastric/GEJ cancers
Multidisciplinary expert panel consisting of a physician, a nurse, and a pharmacist discuss optimal care for patients with CLL from various perspectives.
In this downloadable slideset, you can review the most recent clinical data on new agents in chronic lymphocytic leukemia.
Gain expert perspectives on using BTK inhibitors in the management of B-cell malignancies with this symposium Webcast from Clinical Care Options
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.